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introduction: Despite the established evidence on benefits of controlling raised blood 
pressure and development of several guidelines on detection and management of
hypertension, people often have untreated or uncontrolled hypertension. In this context, 
we undertook this study to identify the barriers existing in hypertension treatment and 
control in the municipalities of Kathmandu district in Nepal.
Methods: This was a community based, cross-sectional mixed method study con-
ducted in the municipalities of Kathmandu district in Nepal between January and July 
2015. Among 587 randomly selected participants, the aware hypertensive participants 
were further assessed for the treatment and control of hypertension. For qualitative 
component, 20 participants having uncontrolled hypertension took part in two focused 
group discussions and two cardiac physicians participated in in-depth interviews.
results: Out of 587 participants screened, 191 (32.5%) were identified as hypertensive. 
Among 191 hypertensive participants, 118 (61.8%) were aware of their problem. Of the 
118 aware hypertensive participants, 93 (78.8%) were taking medicines, and among 
those treated, 46 (49.6%) had controlled hypertension. Proportions of participants taking 
anti-hypertensive medications varied significantly with age groups, ethnicity, occupation 
and income. Hypertension control was significantly associated with use of combination 
therapy, adherence to medication, follow-up care, counseling by health-care providers, 
and waiting time in hospital. Being worried that the medicine needs to be taken life-
long, perceived side effects of drugs, non-adherence to medication, lost to follow-up, 
inadequate counseling from physician, and lack of national guidelines for hypertension 
treatment were the most commonly cited barriers for treatment and control of hyperten-
sion in qualitative component of the research.
conclusion: Large proportion of the hypertensive population has the untreated and the 
uncontrolled hypertension. Efforts to dispel and dismantle the myths and barriers related 
to hypertension treatment and control are warranted to reduce the consequences of 
uncontrolled hypertension.
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inTrODUcTiOn
Hypertension is one of the most common causes of cardiovas-
cular disease (CVD) and deaths globally (1). A relatively small 
increase in blood pressure affects the incidence of various CVD 
including coronary artery disease, congestive heart failure, renal 
insufficiency, peripheral vascular disease, and stroke (2, 3).
Despite the evidence on benefits of lowering blood pressure, 
and the existence of several guidelines on detection and manage-
ment of hypertension, untreated and uncontrolled hypertension 
occur largely in the society (4, 5). Literatures suggest that nearly 
half of aware hypertensive cases do not take treatment and more 
than half of those treated have uncontrolled blood pressure (4, 5).
Several factors relating to patients, physician, and health-care 
system are responsible for poor treatment and suboptimal control 
of hypertension (6, 7). Lack of adequate treatment, reluctance to 
change the lifestyle, failure to take medications as indicated, non-
adherence to medicine, lack of follow-up, perceived side effect 
of drug, therapeutic inertia, communication barriers between 
health-care providers and recipient, non-compliance to treat-
ment guidelines, and lack of access to health care are some of 
the mostly cited impediments for hypertension treatment and 
control (6–16). However, there is the dearth of similar studies in 
Nepal. We undertook this study to identify the barriers existing 
in hypertension treatment and control in the newly declared 
municipalities of Kathmandu.
MaTerials anD MeThODs
study Design, settings, and Participants
This was a community-based, cross-sectional study conducted in 
the newly declared (declared in December 2014) municipalities of 
Kathmandu district, Nepal, between January and July 2015. The 
10 municipalities, which contain more than 300,000 population, 
are located on the outskirts of Kathmandu metropolitan city (17).
Total 587 persons having age between 18 and 70  years and 
registered as permanent residents of the study areas at the time 
of study were selected by multistage stratified sampling method 
and screened for hypertension. The selection process has been 
described in details elsewhere (18). Among the persons screened, 
the aware hypertensive participants were included in the quantita-
tive part of the study. For qualitative method, 20 participants, who 
had uncontrolled hypertension at the time of interview and were 
not included in quantitative component, were selected for two 
focused group discussions (FGD). Similarly, two cardiac physi-
cians from tertiary hospital took part in in-depth interview (IDI).
Data collection
Quantitative data were collected via face-to-face interview, 
anthropometric measurements, and clinical examinations. 
Fifteen medical professionals were recruited and trained in data 
collection methods. Investigators themselves were involved in 
conducting FGDs and IDIs for qualitative data collection.
Face-to-face Interview
The survey questionnaire (derived from WHO STEPwise ques-
tionnaires) covered the demographics and health behaviors of 
respondents (19). Demographic information included age, sex, 
ethnicity, marital status, years at school, and primary occupation. 
The health behaviors included tobacco use, alcohol consump-
tion, fruit and vegetable consumption, and physical activity. In 
addition, questionnaires related to knowledge and perception of 
hypertension; awareness, treatment, and control of hypertension; 
antihypertensive medication; adherence; health-care facility; and 
health-care providers were also included in survey tool.
Tobacco Use and Alcohol Consumption
Questions were asked to determine the current users of tobacco 
and alcohol.
Diet
Seventy-two hour dietary recall was used to estimate fruit and 
vegetable consumption. Determination of the amount of fruit 
and vegetables consumed was aided by pictorial show cards and 
standard measuring cups.
Physical Activity
Seven day history of physical activity was recorded. The physical 
activity related to work, transport, and recreational activities 
were categorized into vigorous, moderate, and low levels of activ-
ity in accordance with published guidelines (20, 21). Vigorous 
physical activity was defined as any activity that had more than six 
Metabolic Equivalent of Tasks (MET). Moderate physical activ-
ity was the activity that had MET values between three and six 
(20). Physical activity having less than three METs, like spending 
time sitting at a desk, traveling in a car, bus or train, etc., was 
considered low or sedentary physical activity.
Diabetes
Participants were requested to provide information on diabetic 
status or medication history.
Knowledge and Perception of Hypertension
Knowledge-based questions recorded the respondent’s under-
standing on high blood pressure. Perception entailed the per-
ceived severity, chronicity, complication, and manageability of 
hypertension.
Awareness, Treatment, and Control of Hypertension
Participants were asked whether they were aware of the raised 
blood pressure they had. Information regarding type and name of 
currently used antihypertensive drugs was also obtained. Reasons 
behind the stoppage of or not initiating the antihypertensive 
medicine were collected from the hypertensive respondents who 
were not in treatment.
Adherence
Morisky four-Item Self-Report MEASURE of Medication-taking 
Behavior tool was used to assess the adherence of antihyperten-
sive medication among participants who were on treatment. It 
contained four questions relating to forgetfulness to take the 
medicine (two questions) and self-adjustment of medicine dos-
ages (two questions) – with options “Yes,” “No” in reply. The “Yes” 
rated answers were assigned a value of 1, and “No” as 0. Then, the 
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aggregate number was categorized as 0 for high adherence, 1 to 
2 for medium adherence, and 3 to 4 for low adherence (22, 23).
Health-care Facility and Health-care Providers
Health-care facility and health-care provider-related question-
naires were designed to assess the level of access to health 
facility, waiting time, types of health facility, types of health-care 
providers, communication with health-care providers on lifestyle 
modification, and satisfaction to service provider.
Anthropometric Measurement
Height and weight were measured using the digital weighing 
machines and the portable standard stature scales, respectively, 
from which body mass index (BMI) was calculated. Waist and hip 
circumferences were also measured by non-stretchable measur-
ing tape in order to determine the waist–hip ratio.
Clinical Examination
Trained data collectors measured blood pressure using an 
aneroid sphygmomanometer. Before taking the measurements, 
participants were requested to sit quietly and rest for 15 min with 
legs uncrossed. Three readings of the systolic and diastolic blood 
pressure were taken with 3-min rest between each reading, and 
the mean of second and third reading was used for analysis.
Focused Group Discussion
Focus group discussion was the key method to explain the 
patient-related and system-related barriers in hypertension 
treatment and control. Questions were asked to hypertensive 
participants who had uncontrolled blood pressure. FGD guide-
lines consisted of knowledge and perception of hypertension; 
barriers in treatment and control of hypertension; antihyperten-
sive medication; adherence; follow-up; health-care facility; and 
health-care providers.
In-depth Interview
In-depth interview was used to explore the problems and inter-
pret issues in multidimensional ways. Two cardiac physicians 
were asked about the health system (human work force and other 
resources) and health-care provider-related barriers (adherence 
to clinical guidelines, advice for lifestyle modifications).
Operational Definitions
Standard operational definitions were adopted for key variables 
to maintain consistency and uniformity of the information.
Aware Hypertensive
A person was defined as aware if he/she was hypertensive and 
self-reported the condition (5).
Treatment
Treatment is defined as having a history of current antihyperten-
sive drug therapy at the time of the interview (24).
Controlled Blood Pressure
Control of hypertension was defined as blood pressure below 
140/90 mmHg while taking treatment (5).
Poor
Those participants having income less than 40,933 Nepalese 
Rupees per annum were considered the poor (25).
Current Smoker
Current smokers were defined as those who reported smoking 
any tobacco product within last 30 days.
Current Alcohol Drinkers
Those who consumed alcohol within last 30 days were considered 
current alcohol drinkers (26).
Sufficient Fruit and Vegetables Intake
Intake of at least 400 g of fruit and vegetables in a day was regarded 
as sufficient (27).
Sufficient Physical Activity
Sufficient physical activity was defined as ≥600 METs of moder-
ate and vigorous activity in a week (20).
Hypertension
The diagnostic criterion for hypertension was set as a systolic 
blood pressure ≥140  mmHg and/or a diastolic blood pressure 
≥90 mmHg as recommended by Joint National Committee-VII. 
The persons who were using antihypertensive medicine were also 
considered as hypertensive (28).
Diabetes
Self-reported use of any anti-diabetic medication was the diag-
nostic criteria for diabetes.
Validity and reliability
Prior using the tools, pilot testing survey was conducted among 
20 participants, and changes were made in the data collection 
tools accordingly. Data enumerators were trained in data collec-
tion methods to standardize the data collection procedure and 
maintain the data quality. Operational definitions were followed 
as per the WHO, international and national guidelines. To collect 
valid and reliable data, investigators, themselves, conducted FGD 
and IDI.
ethical consideration
The study protocol was reviewed and approved by Ethical Review 
Board of the Nepal Health Research Council, Kathmandu. 
Written consent was obtained from all participants after detailed 
explanation of research purpose and assurance of maintaining 
privacy and confidentiality. Those who needed further treatment 
were referred to tertiary treatment centers.
Data Management and analysis
Data were compiled, edited, and checked to maintain consist-
ency. Duplications were removed before coding and entering 
them in Epidata V.2.1. Data were then exported to SPSS V.16.0 
for analysis.
Frequencies and percentages were calculated to identify the 
distribution of sociodemographic characteristics. Chi-square 
test was conducted for comparing proportions of categorical 
TaBle 1 | sociodemographic characteristics by gender among aware hypertensive participants.
characteristics categories gender Total P value
Male (%) Female (%)
Age groups <40 years 5 (9.3) 8 (12.5) 13 (11.0) 0.67
40–59 years 31 (57.4) 39 (60.9) 70 (59.3)
≥60 years 18 (33.3) 17 (26.6) 35 (29.7)
Education No formal education 8 (14.8) 12 (25.0) 48 (40.7) <0.01
Primary and lower 8 (14.8) 40 (62.5) 19 (16.1)
Secondary 26 (48.1) 11 (17.2) 35 (29.7)
Bachelor and higher 12 (22.2) 9 (14.1) 16 (13.6)
Ethnicity Brahman 18 (33.3) 21 (32.8) 39 (33.1) 0.38
Chhetri 15 (27.8) 19 (29.7) 34 (28.8)
Newar 15 (27.8) 11 (17.2) 26 (22.0)
Others (Dalit, Janajati) 6 (11.1) 13 (20.3) 19 (16.1)
Occupation Job 15 (27.8) 2 (3.1) 17 (14.4) <0.01
Self employed 15 (27.8) 4 (6.2) 19 (16.1)
Homemaker 8 (14.8) 53 (82.8) 61 (51.7)
Others (unemployed, retired)  16 (29.6) 5 (7.8) 21 (17.8)
Poverty Above poverty line 31 (57.4) 32 (48.4) 62 (52.5) 0.04
Below poverty line 23 (42.6) 33 (51.6) 56 (47.5)
Primary and lower education, grade 1–5; secondary, grade 6–12; Job, governmental or non-governmental employment; self-employed, working for oneself as a freelancer or the 
owner of a business or working in own farm; homemaker, a person, especially a housewife, who manages a home; other occupation, volunteer or student or unemployed or retired; 
below poverty line, income less than 40,933 Nepalese rupees per annum.
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variables with respect to treatment and control of hypertension. 
All tests were two-tailed, and p < 0.05 was considered statistically 
significant.
Qualitative data were analyzed using thematic analysis 
method. Information was coded with keyword approach, cat-
egorized, and finalized with the appropriate theme. Researchers 
independently read the transcripts line by line and remained 
neutral to code the documents. In second stage, open codes were 
merged together to develop the theme.
resUlTs
sociodemographic characteristics
Out of 587 participants screened, 191 were identified as hyper-
tensives. Among 191 hypertensive participants, 118 were aware 
of their condition. Aware hypertensive participants included 
64 (54.2%) females and 54 (45.8%) males. The majority of 
aware hypertensive participants (59.3%) had age between 
40 and 60  years. More than half of the participants (56.8%) 
had either no formal education or had attained primary and 
lower than primary education. Levels of education and types 
of occupation varied significantly with gender (p  <  0.001) 
(Table  1).
Twenty participants, equal numbers of male and female, took 
part in two separate focused grouped discussions. All participants 
had age more than 40 years. The majority of participants (70%) 
had less than secondary education. More than three quarters 
(78%) of participants belonged to Brahmin and Chhetri ethnic 
groups. Two key informants, cardiology physicians from a 
tertiary care center, provided in-depth information on patient-
related and physician-related barriers in treatment and control 
of hypertension.
Treatment of hypertension
Sociodemographic Characteristics and Treatment of 
Hypertension
Among 118 aware hypertensive participants, 93 (78.8%) were tak-
ing medicines for hypertension. The majority of the participants 
under medication, who visited other than government hospitals 
(71%), had their health checkup done by specialist physician 
(58.0%) and were using calcium channel blockers (53.8%) for 
the control of hypertension. Two participants had been to pri-
mary health-care centers for the treatment of hypertension. The 
remaining participants (25 out of 118) had either not started (16 
out of 25) or discontinued (9 out of 25) medication.
Almost equal proportions of male and female were on anti-
hypertensive treatment. However, proportions of participants 
taking anti-hypertensive medications varied significantly with 
age groups, ethnicity, occupation, and income (Table 2). There 
was no statistically significant difference in treatment status by 
education levels.
Knowledge, Perception, and Treatment of 
Hypertension
More than three quarters (98 of 118) of aware hypertensive 
participants perceived hypertension as severe health condition. 
Similarly, 79.6% (94 of 118) of participants agreed that hyper-
tension could have complications in future if left untreated. 
The majority of the respondents (72 of 118) also believed that 
hypertension was a chronic condition, whereas almost all (107 
of 118) thought hypertension could be managed by lifestyle 
modification. However, participants’ perceptions on severity, 
complications, chronicity, and manageability of hypertension 
were not associated with its treatment. Participants who knew 
the normal blood pressure levels were more likely to take 
TaBle 2 | Factors associated with treatment and control of hypertension among aware (N1 = 118) and treated (N2 = 93) hypertensive participants.
characteristics categories N1 Treatment of hypertension 
among aware hypertensives 
n1 (%)




Total 118 93 (78.8) 93 46 (49.6)
Gender Male 54 42 (77.8) 0.48 42 20 (47.6) 0.77
Female 64 51 (79.7) 51 26 (51.0)
Age groups <40 years 13 7 (58.8) <0.01 7 5 (71.4) 0.48
40–59 years 70 53 (75.7) 53 12 (12.9)
≥60 years 35 33 (94.3) 33 16 (48.5)
Education No formal education 48 36 (75.0) 0.76 36 20 (55.6) 0.08
Primary and lower 19 15 (78.9) 15 4 (26.7)
Secondary 35 28 (80.0) 28 12 (42.9)
Bachelor and higher 16 14 (87.5) 14 10 (71.4)
Ethnicity Brahman 39 36 (92.3) <0.01 36 19 (52.8) 0.65
Chhetri 34 27 (79.4) 27 15 (56.6)
Newar 26 20 (76.9) 20 8 (40.0)
Others (Dalit, Janjati) 19 10 (52.6) 10 4 (40.0)
Occupation Government job 17 12 (70.6) <0.01 12 8 (66.7) 0.54
Self employed 19 10 (52.6) 10 5 (50.0)
Homemaker 61 51 (83.6) 51 25 (49.0)
Others 21 20 (95.2) 20 8 (40.0)
Poverty Above poverty line 62 54 (87.1) 0.04 39 15 (38.5) 0.07
Below poverty line 56 39 (69.6) 54 31 (57.4)
Smoking Yes 28 17 (60.7) 0.01 17 8 (47.1) 0.83
No 90 76 (84.4) 76 38 (50.0)
Alcohol  
consumption
Yes 32 21 (65.6) 0.03 21 9 (42.9) 0.49
No 86 72 (83.7) 72 37 (51.4)
Fruit and 
vegetables intake
Sufficient 15 13 (86.7) 0.42 13 3 (23.1) 0.08
Non-sufficient 103 80 (77.7) 80 43 (53.8)
Physical activity Sufficient 85 64 (75.3) 0.13 64 34 (53.1) 0.30
Non-sufficient 33 29 (87.9) 29 12 (41.4)
BMI ≥25 kg/m2 74 56 (75.7) 0.28 56 29 (51.8) 0.58
<25 kg/m2 44 37 (84.1) 37 17 (45.9)
Diabetes Yes 23 20 (87.0) 0.29 20 11 (55.0) 0.58
No 95 73 (76.8) 73 35 (47.9)
N1, aware hypertensive participants; N2, aware hypertensive participants who were under treatment; n1, proportions of participants who were under treatment; n2, proportions of 
participants having controlled blood pressure; primary and lower education, grade 1–5; secondary, grade 6–12; job, governmental or non-governmental employment; self-employed, 
working for oneself as a freelancer or the owner of a business or working in own farm; Homemaker, a person, especially a housewife, who manages a home; other occupation, 
volunteer or student or unemployed or retired; Below poverty line, income less than 40,933 Nepalese rupees per annum; sufficient fruit and vegetable consumption, intake of ≥400 g 
of fruit and vegetable per day; Sufficient physical activity, ≥600 METs of moderate and vigorous activity in a week.
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antihypertensive treatment than those who did not know about 
it (Table 3).
Barriers to Treatment of Hypertension
More than one-fifth of the participants (25 of 118) were not under 
treatment. Reason behind avoiding treatment was a perception 
that once medicine was taken that should be continued lifelong 
(16 of 25). Similarly, experiencing unwanted effect or fear of long-
term effect of medicines were the other reasons behind quitting 
the medications (8 of 25).
In FGD, the majority of the participants did not like the need 
of long-term use of anti-hypertensive medication and indicated 
it as a main barrier for not initiating the treatment. “If medicine 
is taken once, it cannot be stopped. So, I have not started yet … no, 
I will not take medicine for hypertension in any condition,” a FGD 
participant expressed his denial to take antihypertensive medicine 
though he was aware of severity of uncontrolled hypertension. 
Similarly, most of the participants were also worried about the 
adverse effect of medicine. Some quit medicine after experienc-
ing unwanted effects like weakness, dizziness, headache, and 
abdominal pain. “Medicine causes abdominal discomfort, burning 
sensation of hand and feet and cramping of limbs. So, I stopped tak-
ing medicine” (FGD 1, male, 65 years). None of the participants 
raised the issues of unaffordability of anti-hypertensive drugs as 
a barrier in hypertension treatment.
Physicians also agreed that people had various beliefs on dura-
tion of intake of medicine and its adverse effect, which sometimes 
demotivated patients to continue or initiate medicine. “I have 
encountered several patients who hesitated to take medicine with 
the fear of adverse effect.”
Most of the FGD participants perceived exercise and diet 
control as an alternative to the medicine for effective blood pres-
sure control. They believed that by strictly following the healthy 
behavior they could avoid medicine. Some participants even 
TaBle 4 | association of treatment related factors with control of 
hypertension.




Yes (%) no (%)
Antihypertensive 
medicine
Mono-therapy 35 (44.9) 43 (55.1) 78 0.04
Combination 
or Two and  
more  
medicines
11 (73.3) 4 (26.7) 15 
Access to health 
facility 
<20 min 16 (51.6) 15 (48.4) 31 0.70
≥20 min 27 (47.4) 30 (52.6) 57
Waiting time in 
health facility 
<20 min 22 (66.7) 11 (33.3) 33 0.03
≥20 min 22 (42.3) 30 (57.7) 52 
Adherence to 
medication
High 30 (78.9) 8 (21.1) 38 <0.01
Medium 16 (30.8) 36 (69.2) 52 
Low 0 (0) 3 (100.0) 3 
Types of health- 
care providers
Cardiologist 30 (55.6) 24 (44.4) 54 0.17
Others 16 (41.0) 23 (59.0) 39
Types of health 
facilities 
Government 12 (44.4) 15 (55.6) 27 0.54
Other 34 (51.5) 32 (48.5) 66 
Follow-up 
continuation 
Yes 38 (60.3) 25 (39.7) 63 <0.01
No 7 (24.1) 22 (75.9) 29 
Satisfaction with 
service provider
Yes 43 (52.4) 39 (47.6) 82 0.18





Yes 29 (61.7) 18 (38.3) 47 0.03
No 17 (37.0) 29 (63.0) 46 
TaBle 3 | association of knowledge and perception of hypertension with 
treatment.




Yes (%) no (%)
Awareness on 
normal BP level
Yes 56 (87.5) 8 (12.5) 64 0.02
No 37 (68.5) 17 (31.5) 54 
Perceived  
severity
Yes 77 (78.6) 21 (21.4) 98 0.89
No 16 (80.0) 4 (20.0) 20 
Perceived 
complication
Yes 73 (77.7) 21 (22.3) 94 0.54
No 20 (83.3) 4 (16.7) 24
Perceived  
chronicity
Yes 58 (80.6) 14 (19.4) 72 0.56
No 35 (76.1) 11 (23.9) 46 
Perceived effect of 
lifestyle modification
Yes 85 (79.4) 22 (20.6) 107 0.60
No 8 (72.7) 3 (27.3) 11 
Questions asked to measure each of the above variables – Awareness on normal BP 
level, “Do you know the normal blood pressure level?”; Perceived complication, “Do 
you think high blood pressure will have long-term health complications?”; Perceived 
chronicity, “Do you think that high blood pressure is a life-long disease?”; Perceived 
effect of lifestyle modification, “Can changing lifestyle help to lower high blood pressure?
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shared their unusual practices like taking cold showers every 
morning, drinking plenty of water kept in copper jog, giving up 
evening meal, etc., to control hypertension. “I am drinking plenty 
of water, going on morning walks regularly, taking cold showers, 
and having low salt diet … . In my view, it is good to control pressure 
by lifestyle modifications rather than by taking medicine directly” 
(FGD 2, male, 42 years). A few participants also reported using 
home and herbal remedies for blood pressure control. The herbal 
remedies they frequently used were drinking of juice expressed 
from bitter gourd, sponge gourd, bottle gourd, and aloe vera.
control of hypertension
Among those 93 hypertensive participants under medication, 
46 had controlled hypertension. Hypertension control had no 
statistically significant association with the socio-demographic 
characteristics like gender, age groups, educational level, ethnic-
ity, occupation, and income (Table 2).
There was also no statistically significant association between 
the control of hypertension and smoking, alcohol consumption, 
fruit and vegetables intake, physical exercise, and presence of 
diabetes (Table 2).
Barriers to Control of Hypertension
Participants taking two or more medications separately or in 
combination had significantly higher hypertension control than 
others’ (Table 4). Similarly, the participants who adhered to the 
medications, continued the follow-up care regularly, and received 
the lifestyle modification advice from the physician had more 
control over hypertension. Waiting time in health centers for the 
check up was significantly associated with control of high blood 
pressure. The proportion of controlled hypertensive participants 
did not vary much with types of health facility (government or 
others) and health-care provider (cardiologist or others).
Non-adherence to medication was also a common problem 
observed among FGD participants who were under treatment. 
Some stopped using medicine thinking that they had completely 
recovered from the illness, and some were reducing the dose 
themselves when they felt well. “I am not taking medicine. If my 
pressure crosses the limit, then only I will take medicine. I discon-
tinued using medicine since my pressure lowered down to normal” 
(FGD 2, male, 36 years). In IDI, physicians underlined the treat-
ment non-adherence as one of the main barriers in hypertension 
control. “The main reason behind uncontrolled hypertension is 
non-adherence to medication.”
Lost to follow-up was another pertinent issue identified 
among the uncontrolled hypertensive participants. The majority 
of FGD participants reported that they were not on a regular 
follow-up for having their blood pressure checked up. They 
either neglected it or did not get any clear message about the 
need of follow-up from health-care providers. “I have not gone 
for follow-up. I am following the same regimen from last one and 
a half years. My doctor told me to visit him only if I had problems” 
(FGD 2, female, 55 years). Apart from that, participants living 
relatively far (1 h by bus) from the hospital did not like to visit 
doctor regularly. The majority of the FGD participants also 
reported that they did not receive any proper messages on drug 
use and lifestyle modification from the physicians or from health 
centers. Most of them complained that physician did not provide 
sufficient time to listen to them. Both key informants also agreed 
upon the issue raised by the participants and said it was because 
of time constraint. “Clinicians are mostly overwhelmed by the 
large number of patients. They could not pay enough attention 
to their patients.” They also indicated that because of lack of 
clear national guidelines, there was no consensus in selecting 
both pharmacological and non-pharmacological interventions 
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for the management of hypertension in Nepal. “We do not have 
any national guidelines on hypertension treatment. That brings 
inconsistency and lack of uniformity among physicians while 
selecting the type of anti-hypertensive medicine, dosage and non-
pharmacological interventions.”
DiscUssiOn
Study findings suggested that diagnosed but untreated and treated 
but uncontrolled hypertension occur largely in the study popula-
tion. Treatment status varied significantly with age groups, eth-
nicity, occupation, and household income. Long-term treatment 
need and perceived side effects of anti-hypertensive medicines 
were the major barriers in treatment of hypertension. Similarly, 
intake of single antihypertensive medicine, long waiting time at 
health facility, non-adherence to medication, dis-continuation of 
follow-up care, lack of uniformity in hypertension treatment, and 
failing to deliver the lifestyle modification messages from health-
care providers were the major barriers in control of hyperten-
sion. Small sample size and the restriction of FGDs to controlled 
hypertensive participants were the concerning limitations of the 
study.
Our study found that 78.8% (93 of 118) of aware hypertensive 
participants were under anti-hypertensive medication and 49.4% 
(46 of 93) of the participants who took medicine had controlled 
blood pressure. The findings were higher than the results of a 
study conducted in similar setting in Kathmandu in 2006, which 
revealed that hypertension treatment rate among aware hyper-
tensive participants was 63.3% and hypertension control rate 
among the participants on medication 22.8% (29). The result of a 
similar study conducted in urban slum in India reported higher 
percentage of hypertension control (52.9%) than ours (30). The 
proportion of participants having controlled blood pressure 
among those receiving treatment was comparable to the preva-
lence of hypertension control reported in high-income country 
(40.7%), low-income country (40.2%), upper–middle-income 
country (32.3%) and low–middle-income country (26.9%) (4). 
However, these findings were based on study conducted among 
hypertensive participants as a whole between January 2003 and 
December 2009.
Our study showed that participants intentionally avoided 
treatment because of a long-term need of medication and a 
fear of side effects. Similar findings were reported from various 
studies conducted in Canada, Netherlands, and Thailand. They 
reported a fear of long-term problems from taking drugs 
(13). A  metaanalysis synthesized the findings that people had 
widespread caution about taking medicines. They feared drug 
dependency and tolerance and the potential harm from long-
term medication (8). In our study, some participants who were 
reluctant to take medicine showed considerable preference to 
non-pharmacological measures like home remedies or lifestyle 
modification instead. A Chilean study also found that 8.5% of 
patients in their primary care-based cohort were managed exclu-
sively with other than medicine (31). None of the participants 
reported the medical care expenses as a barrier in hypertension 
treatment and follow-up care. This result should cautiously be 
generalized to the other parts of the country where the majority 
of people has comparatively less purchasing capacity than the 
people living in municipalities of Kathmandu (32).
The use of two or more medications combinedly or separately 
was associated with hypertension control. Similar to our find-
ing, a meta-analysis conducted among 42 trials concluded that 
combination therapy (two different classes) gave five times better 
result in controlling blood pressure than doubling the dose of one 
drug (33). Evidence from Pakistan suggests that the prescription 
of optimal medications also contributes significantly to the better 
adherence of medication (10). Even though use of combination 
or multidrug therapy had better result in controlling hyperten-
sion, a large percentage of participants (83.8%) in our study were 
receiving mono-therapy for the treatment of hypertension. That 
was contrasted with a study conducted outside Nepal where the 
majority of the patients (57.1%) used combination of drugs (31). 
Our study found that calcium channel blocker was the most 
frequently used medicine among the study participants. Even 
though the ongoing free health-care policy endorsed by Nepal 
government listed calcium channel blocker as a freely available 
essential anti-hypertensive drug at primary health-care cent-
ers, insufficient supply of free essential drugs is another part of 
discussion and out of scope of the study (34). Similarly, very 
nominal number of participants (2 out of 93) visited primary 
health-care centers for the treatment of hypertension and none 
of them were receiving free medication from the centers. This 
suggests a major gap in hypertension treatment and application of 
free anti-hypertensive drug policy in Nepal. Similarly, our study 
showed the participants who were adhered to the medications 
had more control over hypertension. Non-adherence to medica-
tion is directly associated with poor outcome of disease (9, 35). 
Participants mainly liked to adjust the dose – by either increasing 
or decreasing the dosage of medication – based on the severity 
of symptoms they felt. Similar practice of avoiding or reducing 
the dose of medication deliberately was also observed among 
the Dutch, British, American, Brazilian, and Thai. They chose to 
reduce the dosage of medicine thinking that their blood pressure 
was controlled (13).
Lost to follow-up was another barrier seen among the uncon-
trolled hypertensive participants. Participants who continued 
the follow-up care to the health-care providers regularly had 
better control of hypertension than those who did not. Timely 
maintaining the follow-up visit ensures the good compliance over 
medication, thus controlling hypertension (36, 37). In Malaysia, 
patients are reluctant to visit physicians for the second time 
because of their denial of their condition, or, having failed to fol-
low the lifestyle advice on diet and exercise, or low health literacy 
given by physicians (15). But, in our study, the majority of the 
participants missed the follow-up date because of lack of proper 
information about follow-up need from health-care providers.
Our study found that the participants who received the proper 
counseling in life-style modification and drug use had high con-
trol of blood pressure. Key informants and participants reported 
that health-care providers spent very insufficient time to engage 
with patients because of time constraint. Evidence suggests that 
the communication barriers between heath-care providers and 
patients impede effective control of hypertension (38). Moreover, 
regular follow-up care also leads to high compliance over 
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treatment. A randomized controlled trial conducted in Pakistan 
found that relative adherence in people seeking care from general 
practitioners who were trained in scheduling follow-up visits, 
providing satisfactory consultation sessions with explanation of 
non/pharmacological interventions was 50% higher than in those 
consulting untrained general practitioners (39). Adequate coun-
seling of patients on treatment plan, medications, and lifestyle 
interventions can play a substantial role in building trust between 
physician and patient and lead to treatment adherence and hyper-
tension control (12). Researches synthesized the results of 27 
trials and concluded that intensive combined lifestyle counseling 
applied for 12 to 24 months reduced blood pressure level (14). 
However, a Chinese study conducted among 556 hypertensive 
patients found that dietary counseling was ineffective to control 
hypertension (40).
Our study also found some system-related barrier like long 
waiting time in hospital and distantly located health-care facilities 
that demotivated people to go for a regular follow-up. A study 
conducted in Africa also echoed the same issues of inconven-
iently located health-care facilities and long waiting times within 
those facilities as the barriers in high blood pressure prevention 
and control (11). Similarly, physician’s unawareness or non-
compliance over hypertension treatment guidelines was another 
pertinent issue that rose in the study could be a physician-related 
barrier in treatment and control of hypertension (6).
cOnclUsiOn
Overall, this study explored the barriers in hypertension treat-
ment and control that were related to persons with hypertension, 
health-care providers, and health system in Kathmandu, Nepal. 
Findings have implication on effectively addressing barriers 
embedded in hypertension treatment and control in Nepali 
urban population through designing multi-faceted strategies 
including health education for increasing hypertension-related 
health literacy in the community, issuing national guidelines 
for hypertension treatment, and introducing policy to overcome 
institutional hurdles.
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